$1.79
Cocrystal Pharma is a biotechnology business based in the US. Cocrystal Pharma shares (COCP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.20 – an increase of 25.71% over the previous week. Cocrystal Pharma employs 12 staff and has a trailing 12-month revenue of around $510,000.
What's in this guide?
Our top picks for where to buy Cocrystal Pharma stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Cocrystal Pharma stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – COCP. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Cocrystal Pharma stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Cocrystal Pharma stock price (NASDAQ: COCP)
Use our graph to track the performance of COCP stocks over time.Cocrystal Pharma shares at a glance
Latest market close | $2.20 |
---|---|
52-week range | $1.33 - $3.10 |
50-day moving average | $1.77 |
200-day moving average | $1.82 |
Wall St. target price | $8.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-1.75 |
Is it a good time to buy Cocrystal Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cocrystal Pharma price performance over time
Historical closes compared with the close of $1.8325 from 2024-10-15
1 week (2024-10-10) | 4.71% |
---|---|
1 month (2024-09-17) | 4.12% |
3 months (2024-07-17) | -18.92% |
6 months (2024-04-17) | 28.15% |
1 year (2023-10-17) | 0.69% |
---|---|
2 years (2022-10-17) | -24.90% |
3 years (2021-10-15) | 94.88% |
5 years (2019-10-17) | 42.05% |
Cocrystal Pharma financials
Revenue TTM | $510,000 |
---|---|
Gross profit TTM | $-8,794,000 |
Return on assets TTM | -46.06% |
Return on equity TTM | -68.86% |
Profit margin | 0% |
Book value | $1.71 |
Market Capitalization | $18.2 million |
TTM: trailing 12 months
Cocrystal Pharma share dividends
We're not expecting Cocrystal Pharma to pay a dividend over the next 12 months.
Have Cocrystal Pharma's shares ever split?
Cocrystal Pharma's shares were split on a 1:12 basis on 10 October 2022. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cocrystal Pharma shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Cocrystal Pharma shares which in turn could have impacted Cocrystal Pharma's share price.
Cocrystal Pharma share price volatility
Over the last 12 months, Cocrystal Pharma's shares have ranged in value from as little as $1.325 up to $3.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cocrystal Pharma's is 1.415. This would suggest that Cocrystal Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cocrystal Pharma overview
Cocrystal Pharma, Inc. , a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp.
Frequently asked questions
nullWhat percentage of Cocrystal Pharma is owned by insiders or institutions?
Currently 30.032% of Cocrystal Pharma shares are held by insiders and 6.678% by institutions. How many people work for Cocrystal Pharma?
Latest data suggests 12 work at Cocrystal Pharma. When does the fiscal year end for Cocrystal Pharma?
Cocrystal Pharma's fiscal year ends in December. Where is Cocrystal Pharma based?
Cocrystal Pharma's address is: 19805 North Creek Parkway, Bothell, WA, United States, 98011 What is Cocrystal Pharma's ISIN number?
Cocrystal Pharma's international securities identification number is: US19188J3005 What is Cocrystal Pharma's CUSIP number?
Cocrystal Pharma's Committee on Uniform Securities Identification Procedures number is: 09072E103
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question